A nanoplasmonic biosensor for label-free multiplex detection of cancer biomarkers.
Jong Uk Lee, Anh H Nguyen, Sang Jun Sim
Index: Biosens. Bioelectron. 74 , 341-6, (2015)
Full Text: HTML
Abstract
The development of highly sensitive, selective and multiplex sensors has become an important challenge for disease diagnosis. In this study, we describe a multiplex biosensor for the detection of cancer biomarkers based on unique plasmon response of single gold nanoparticles (AuNPs) and antibody-antigen binding activity. To demonstrate the ability of the plasmon biosensor to detect and quantify cancer biomarkers: a panel of biomarkers, including α-fetoprotein (AFP), carcinoembryonic antigen (CEA) and prostate specific antigen (PSA) was used as a model analyte for multiple detection. A novel and sensitive multiplex biosensor was developed by immobilizing plasmonic nanoparticles in a site-specific manner and functionalized with monoclonal antibodies that recognize the target protein on hydrophilic-hydrophobic patterned glass slide. The proposed multi-analyte biosensor exhibited outstanding selectivity and sensitivity. The limit of detection was determined to be 91 fM, 94 fM and 10 fM for AFP, CEA and PSA from patient-mimicked serum, respectively. Finally, using this sensing strategy, this platform presents an excellent approach for versatile molecular diagnostics in both research and clinical medical fields.Copyright © 2015 Elsevier B.V. All rights reserved.
Related Compounds
Related Articles:
2015-01-03
[Vaccine 33(2) , 346-53, (2014)]
2014-01-01
[BMC Biotechnol. 14 , 962, (2015)]
Process development for scum to biodiesel conversion.
2015-06-01
[Bioresour. Technol. 185 , 185-93, (2015)]
2015-06-01
[Bioresour. Technol. 185 , 49-55, (2015)]
Investigation of the interactions between the EphB2 receptor and SNEW peptide variants.
2014-12-01
[Growth Factors 32(6) , 236-46, (2014)]